Return to homepagePandemic Pact

to evaluate the safety, immunogenicity, and potential efficacy of a candidate vaccine to prevent COVID-19 infection and/or disease in the South African population

Grant number: INV-021500

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $15,000,000

  • Funder

    Gates Foundation

  • Principal Investigator

    N/A

  • Research Location

    United States of America

  • Lead Research Institution

    Novavax, Inc.

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A